Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Valeo Pharmainc (VPH.TO)

Valeo Pharmainc (VPH.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Valeo Pharmainc 16667, Hymus Boulevard Kirkland QC H9H 4R9 CAN

https://www.valeopharma.com P: 514-694-0150 F: 514-694-0865

Description:

Valeo Pharma Inc is a Canadian specialty pharmaceutical company focused on acquiring either through acquisitions, in-licensing, or similar arrangements. The company operates in two divisions: Branded prescription products and hospital specialty products. Its product portfolio includes medicines for Respiratory/Allergy, Ophthalmology, Neurology, and Oncology.

Key Statistics

Overview:

Market Capitalization, $K 4,440
Shares Outstanding, K 98,657
Annual Sales, $ 53,910 K
Annual Net Income, $ -27,808 K
Last Quarter Sales, $ 12,601 K
Last Quarter Net Income, $ -8,192 K
60-Month Beta 1.30

Growth:

1-Year Return -80.00%
3-Year Return -95.16%
5-Year Return -84.48%
5-Year Revenue Growth 65.20%

Per-Share Information:

Most Recent Earnings -0.08 on 09/12/24
Next Earnings Date 09/11/24
Earnings Per Share ttm -0.37
EPS Growth vs. Prev Qtr 0.00%
EPS Growth vs. Prev Year 0.00%
Dividend Payout Ratio 0.00%

VPH.TO Ratios

Ratio
Price/Earnings ttm N/A
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % N/A
Return-on-Assets % -82.64%
Profit Margin % -51.58%
Debt/Equity N/A
Price/Sales 0.07
Price/Book N/A
Book Value/Share -0.64
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar